Intrinsic Value
NeuBase Therapeutics, Inc. (NBSE)
$0.4489
+0.03 (+6.63%)
| Enterprise Value | - |
|---|---|
| Net Debt | -17.16 |
| Equity Value | - |
| Shares Outstanding | 1.62 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt